Bone marrow cancer drug shows success in treatment of rare blood disorder NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia.

https://www.nih.gov/news-events/news-releases/bone-marrow-cancer-drug-shows-success-treatment-rare-blood-disorder